onset', the delay in diagnosis was 16 years. Laboratory studies revealed elevated CK of 406 IU/L and ALT of 46 IU/L. ECG and EchoCG were normal; normal values of motor and sensory nerves ENG; needle EMG revealed myopathic MUPs in the proximal and trunk muscles with spontaneous activity (FP, PSW, and myotonic discharges in paraspinal and biceps of the arm). Leukocyte acid α-D-glucosidase activity 5.8 nM/mg/h (reference: 13.00-53.60). The patient has typical clinical and laboratory changes of LOPD with proximal muscular weakness and respiratory insufficiency without cardiac complications. Molecular DNA analysis revealed two compound heterozygous mutations: c.743T>C (pLe248Pro), described in HGMD database (CMO82746), and novel mutation c.2799+4A>G (pathogenicity of this mutation requires further investigation).
The remaining four patients diagnosed with LOPD in Russia (mean diagnostic delay of 12 years) have known mutations in comparison with this fi rst described case. The patient has just started enzyme replacement therapy with infusions of recombinant human acid-α-glucosidase (rhGAA; 20 mg/kg body weight) with a slight positive effect which should be assessed in detail in the near future.
